379 related articles for article (PubMed ID: 15930137)
1. Insights into Lafora disease: malin is an E3 ubiquitin ligase that ubiquitinates and promotes the degradation of laforin.
Gentry MS; Worby CA; Dixon JE
Proc Natl Acad Sci U S A; 2005 Jun; 102(24):8501-6. PubMed ID: 15930137
[TBL] [Abstract][Full Text] [Related]
2. Lafora disease proteins malin and laforin are recruited to aggresomes in response to proteasomal impairment.
Mittal S; Dubey D; Yamakawa K; Ganesh S
Hum Mol Genet; 2007 Apr; 16(7):753-62. PubMed ID: 17337485
[TBL] [Abstract][Full Text] [Related]
3. Regulation of the autophagic PI3KC3 complex by laforin/malin E3-ubiquitin ligase, two proteins involved in Lafora disease.
Sanchez-Martin P; Lahuerta M; Viana R; Knecht E; Sanz P
Biochim Biophys Acta Mol Cell Res; 2020 Feb; 1867(2):118613. PubMed ID: 31758957
[TBL] [Abstract][Full Text] [Related]
4. Regulation of glycogen synthesis by the laforin-malin complex is modulated by the AMP-activated protein kinase pathway.
Solaz-Fuster MC; Gimeno-Alcañiz JV; Ros S; Fernandez-Sanchez ME; Garcia-Fojeda B; Criado Garcia O; Vilchez D; Dominguez J; Garcia-Rocha M; Sanchez-Piris M; Aguado C; Knecht E; Serratosa J; Guinovart JJ; Sanz P; Rodriguez de Córdoba S
Hum Mol Genet; 2008 Mar; 17(5):667-78. PubMed ID: 18029386
[TBL] [Abstract][Full Text] [Related]
5. Laforin is required for the functional activation of malin in endoplasmic reticulum stress resistance in neuronal cells.
Zeng L; Wang Y; Baba O; Zheng P; Liu Y; Liu Y
FEBS J; 2012 Jul; 279(14):2467-78. PubMed ID: 22578008
[TBL] [Abstract][Full Text] [Related]
6. Impaired malin expression and interaction with partner proteins in Lafora disease.
Skurat AV; Segvich DM; Contreras CJ; Hu YC; Hurley TD; DePaoli-Roach AA; Roach PJ
J Biol Chem; 2024 May; 300(5):107271. PubMed ID: 38588813
[TBL] [Abstract][Full Text] [Related]
7. Genetic depletion of the malin E3 ubiquitin ligase in mice leads to lafora bodies and the accumulation of insoluble laforin.
DePaoli-Roach AA; Tagliabracci VS; Segvich DM; Meyer CM; Irimia JM; Roach PJ
J Biol Chem; 2010 Aug; 285(33):25372-81. PubMed ID: 20538597
[TBL] [Abstract][Full Text] [Related]
8. Interdependence of laforin and malin proteins for their stability and functions could underlie the molecular basis of locus heterogeneity in Lafora disease.
Mittal S; Upadhyay M; Singh PK; Parihar R; Ganesh S
J Biosci; 2015 Dec; 40(5):863-71. PubMed ID: 26648032
[TBL] [Abstract][Full Text] [Related]
9. Lafora disease proteins laforin and malin negatively regulate the HIPK2-p53 cell death pathway.
Upadhyay M; Gupta S; Bhadauriya P; Ganesh S
Biochem Biophys Res Commun; 2015 Aug; 464(1):106-11. PubMed ID: 26102034
[TBL] [Abstract][Full Text] [Related]
10. Deciphering the role of malin in the lafora progressive myoclonus epilepsy.
Romá-Mateo C; Sanz P; Gentry MS
IUBMB Life; 2012 Oct; 64(10):801-8. PubMed ID: 22815132
[TBL] [Abstract][Full Text] [Related]
11. Ubiquitin conjugating enzyme E2-N and sequestosome-1 (p62) are components of the ubiquitination process mediated by the malin-laforin E3-ubiquitin ligase complex.
Sánchez-Martín P; Romá-Mateo C; Viana R; Sanz P
Int J Biochem Cell Biol; 2015 Dec; 69():204-14. PubMed ID: 26546463
[TBL] [Abstract][Full Text] [Related]
12. Increased laforin and laforin binding to glycogen underlie Lafora body formation in malin-deficient Lafora disease.
Tiberia E; Turnbull J; Wang T; Ruggieri A; Zhao XC; Pencea N; Israelian J; Wang Y; Ackerley CA; Wang P; Liu Y; Minassian BA
J Biol Chem; 2012 Jul; 287(30):25650-9. PubMed ID: 22669944
[TBL] [Abstract][Full Text] [Related]
13. Novel glycogen synthase kinase 3 and ubiquitination pathways in progressive myoclonus epilepsy.
Lohi H; Ianzano L; Zhao XC; Chan EM; Turnbull J; Scherer SW; Ackerley CA; Minassian BA
Hum Mol Genet; 2005 Sep; 14(18):2727-36. PubMed ID: 16115820
[TBL] [Abstract][Full Text] [Related]
14. Loss of laforin or malin results in increased Drp1 level and concomitant mitochondrial fragmentation in Lafora disease mouse models.
Upadhyay M; Agarwal S; Bhadauriya P; Ganesh S
Neurobiol Dis; 2017 Apr; 100():39-51. PubMed ID: 28063983
[TBL] [Abstract][Full Text] [Related]
15. Co-chaperone CHIP stabilizes aggregate-prone malin, a ubiquitin ligase mutated in Lafora disease.
Rao SN; Sharma J; Maity R; Jana NR
J Biol Chem; 2010 Jan; 285(2):1404-13. PubMed ID: 19892702
[TBL] [Abstract][Full Text] [Related]
16. Laforin, the dual-phosphatase responsible for Lafora disease, interacts with R5 (PTG), a regulatory subunit of protein phosphatase-1 that enhances glycogen accumulation.
Fernández-Sánchez ME; Criado-García O; Heath KE; García-Fojeda B; Medraño-Fernández I; Gomez-Garre P; Sanz P; Serratosa JM; Rodríguez de Córdoba S
Hum Mol Genet; 2003 Dec; 12(23):3161-71. PubMed ID: 14532330
[TBL] [Abstract][Full Text] [Related]
17. The malin-laforin complex suppresses the cellular toxicity of misfolded proteins by promoting their degradation through the ubiquitin-proteasome system.
Garyali P; Siwach P; Singh PK; Puri R; Mittal S; Sengupta S; Parihar R; Ganesh S
Hum Mol Genet; 2009 Feb; 18(4):688-700. PubMed ID: 19036738
[TBL] [Abstract][Full Text] [Related]
18. Laforin targets malin to glycogen in Lafora progressive myoclonus epilepsy.
Mitra S; Chen B; Wang P; Chown EE; Dear M; Guisso DR; Mariam U; Wu J; Gumusgoz E; Minassian BA
Dis Model Mech; 2023 Jan; 16(1):. PubMed ID: 36511140
[TBL] [Abstract][Full Text] [Related]
19. The laforin-malin complex, involved in Lafora disease, promotes the incorporation of K63-linked ubiquitin chains into AMP-activated protein kinase beta subunits.
Moreno D; Towler MC; Hardie DG; Knecht E; Sanz P
Mol Biol Cell; 2010 Aug; 21(15):2578-88. PubMed ID: 20534808
[TBL] [Abstract][Full Text] [Related]
20. Malin decreases glycogen accumulation by promoting the degradation of protein targeting to glycogen (PTG).
Worby CA; Gentry MS; Dixon JE
J Biol Chem; 2008 Feb; 283(7):4069-76. PubMed ID: 18070875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
